SFG
BMY icon

Summit Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Summit Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$564K Sell
10,405
-25
-0.2% -$1.27K 0.2% 113
2023
Q4 		$535K Sell
10,430
-50
-0.5% -$2.63K 0.2% 115
2023
Q3 		$608K Hold
10,480
– – 0.26% 103
2023
Q2 		$670K Hold
10,480
– – 0.26% 102
2023
Q1 		$726K Hold
10,480
– – 0.28% 98
2022
Q4 		$754K Buy
10,480
+800
+8% +$60.3K 0.3% 95
2022
Q3 		$688K Buy
9,680
+580
+6% +$42.1K 0.29% 97
2022
Q2 		$701K Hold
9,100
– – 0.27% 99
2022
Q1 		$665K Sell
9,100
-1,000
-10% -$67.1K 0.23% 108
2021
Q4 		$630K Buy
10,100
+480
+5% +$28.2K 0.21% 115
2021
Q3 		$569K Hold
9,620
– – 0.21% 118
2021
Q2 		$643K Buy
9,620
+270
+3% +$17.6K 0.24% 105
2021
Q1 		$590K Buy
9,350
+1,000
+12% +$62.2K 0.25% 95
2020
Q4 		$518K Hold
8,350
– – 0.23% 96
2020
Q3 		$503K Hold
8,350
– – 0.25% 94
2020
Q2 		$491K Sell
8,350
-1,100
-12% -$65.8K 0.26% 89
2020
Q1 		$527K Sell
9,450
-200
-2% -$12.2K 0.31% 77
2019
Q4 		$619K Sell
9,650
-1,053
-10% -$60.3K 0.3% 82
2019
Q3 		$543K Sell
10,703
-10,406
-49% -$489K 0.28% 88
2019
Q2 		$958K Sell
21,109
-233
-1% -$10.9K 0.43% 65
2019
Q1 		$1.02M Hold
21,342
– – 0.8% 41
2018
Q4 		$1.11M Hold
21,342
– – 0.94% 33
2018
Q3 		$1.32M Sell
21,342
-800
-4% -$47.5K 0.99% 31
2018
Q2 		$1.23M Sell
22,142
-1,400
-6% -$75.6K 0.95% 32
2018
Q1 		$1.49M Buy
23,542
+1,350
+6% +$86.8K 1.17% 27
2017
Q4 		$1.36M Sell
22,192
-83
-0.4% -$5.19K 1.11% 27
2017
Q3 		$1.42M Sell
22,275
-300
-1% -$17.5K 1.18% 25
2017
Q2 		$1.26M Buy
+22,575
New +$1.23M 1.09% 28

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit Financial Group's BMY Position: Q1 2024 in Review

Summit Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 0.24% in Q1 2024, selling an estimated $1.27K and leaving 10,405 shares worth $564K. The position accounts for 0.2% of the portfolio, ranked #113.

Summit Financial Group first reported a position in BMY in Q2 2017 and has held it in 28 quarters since. The position peaked at $1.49M in Q1 2018. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Summit Financial Group held 10,405 shares of Bristol-Myers Squibb worth $564K as of Q1 2024.
  • Summit Financial Group sold 25 Bristol-Myers Squibb shares in Q1 2024, an estimated $1.27K.
  • Bristol-Myers Squibb made up 0.2% of Summit Financial Group's portfolio in Q1 2024, its #113 holding.
  • Summit Financial Group first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 28 quarters since.
  • Summit Financial Group's Bristol-Myers Squibb position peaked at $1.49M in Q1 2018.
  • 2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.